Who Owns Harmony Biosciences Holdings (HRMY)? 13F Institutional Holders (Q2 2026)

HRMY ranks #1929 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

326 institutions disclose a position in HRMY, but none treat it as a major bet — even venBio Partners LLC, its most concentrated holder, allocates just 3.3% of its own portfolio to it.

California State Teachers Retirement System has added to its HRMY position for two straight quarters, increasing it by $55.0M to reach $56.6M today.

Boston Partners has trimmed its HRMY position for two straight quarters, cutting it by $25.3M while still holding $1.1M.

HRMY is down 1.7% today, but institutions show net buying of $78.7M this quarter — a divergence between today's price move and the underlying institutional flow.

HRMY posted net income of $181.3M over the trailing twelve months, and currently trades at a P/E of 12.7.

• Profitable — net income of $181.3M over the trailing twelve months
• Revenue grew 24.3% year over year
• Net income improved year over year, from $180.9M to $181.3M
• Generated $348.2M in positive operating cash flow
• Current ratio of 3.60x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.46x equity — within a conventional range